HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L D Wang Selected Research

Proto-Oncogene Proteins c-myc

5/2015Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
11/2014Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L D Wang Research Topics

Disease

8Neoplasms (Cancer)
01/2020 - 04/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2008 - 04/2000
2Esophageal Neoplasms (Esophageal Cancer)
09/2021 - 01/2006
2Esophageal Squamous Cell Carcinoma
11/2019 - 11/2014
1Melanoma (Melanoma, Malignant)
09/2021
1Ischemic Stroke
08/2021
1Chronic Disease (Chronic Diseases)
08/2021
1Stroke (Strokes)
08/2021
1Small Cell Carcinoma
08/2017
1Lymphatic Metastasis
08/2017
1Hypersensitivity (Allergy)
01/2016
1Diarrhea
01/2016
1Visceral Pain
01/2016
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2016
1Hyperalgesia
01/2016
1Atrophic Gastritis
05/2015
1Adenocarcinoma
05/2015
1Hyperplasia
11/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2012
1Adenocarcinoma of Lung
08/2012
1Uterine Cervical Dysplasia
07/2008
1Carcinoma (Carcinomatosis)
01/2008
1Ovarian Neoplasms (Ovarian Cancer)
01/2008
1Peptic Esophagitis (Reflux Esophagitis)
01/2006
1Lung Neoplasms (Lung Cancer)
05/2005
1Microsatellite Instability
10/2001

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
08/2017 - 01/2008
3Messenger RNA (mRNA)IBA
01/2016 - 04/2000
3AntigensIBA
05/2015 - 10/2001
2Cyclin B1IBA
05/2015 - 11/2014
2EnzymesIBA
05/2015 - 11/2014
2Proto-Oncogene Proteins c-mycIBA
05/2015 - 11/2014
2Recombinant ProteinsIBA
05/2015 - 11/2014
2AutoantibodiesIBA
05/2015 - 11/2014
2ImmunosorbentsIBA
05/2015 - 11/2014
1phosphatidyl-N-monomethylaminoethanolIBA
09/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2021
1Chimeric Antigen ReceptorsIBA
01/2020
1Riboflavin (Vitamin B2)FDA LinkGeneric
11/2019
1Chromogranin AIBA
08/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2016
1ErbB Receptors (EGF Receptor)IBA
08/2012
1Gefitinib (Iressa)FDA Link
08/2012
1Annexin A1IBA
07/2008
1ParaffinIBA
07/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2008
1glucose-regulated proteinsIBA
01/2008
1Small Interfering RNA (siRNA)IBA
01/2008
1O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA
01/2006
1TransferasesIBA
01/2006
1Glutathione (Reduced Glutathione)IBA
01/2006
1RadonIBA
05/2005
1Histocompatibility Antigens Class IIBA
10/2001
1DNA (Deoxyribonucleic Acid)IBA
10/2001
1hydrogen sulfite (bisulfite)IBA
04/2000
1Codon (Codons)IBA
04/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
08/2012 - 01/2008
1Therapeutics
08/2021
1Acupuncture Points (Acupuncture Point)
01/2016
1Moxibustion
01/2016